Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
Münch A, Mihaly E, Nagy F, Madisch A, Kupčinskas J, Miehlke S, Bohr J, Bouma G, Guardiola J, Belloc B, Shi C, Aust D, Mohrbacher R, Greinwald R, Munck LK. Münch A, et al. Among authors: mohrbacher r. United European Gastroenterol J. 2021 Sep;9(7):837-847. doi: 10.1002/ueg2.12131. Epub 2021 Aug 20. United European Gastroenterol J. 2021. PMID: 34414678 Free PMC article. Clinical Trial.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Andus T, Kocjan A, Müser M, Baranovsky A, Mikhailova TL, Zvyagintseva TD, Dorofeyev AE, Lozynskyy YS, Cascorbi I, Stolte M, Vieth M, Dilger K, Mohrbacher R, Greinwald R; International Salofalk Suppository OD Study Group. Andus T, et al. Among authors: mohrbacher r. Inflamm Bowel Dis. 2010 Nov;16(11):1947-56. doi: 10.1002/ibd.21258. Inflamm Bowel Dis. 2010. PMID: 20310020 Clinical Trial.
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Tromm A, Bunganič I, Tomsová E, Tulassay Z, Lukáš M, Kykal J, Bátovský M, Fixa B, Gabalec L, Safadi R, Kramm HJ, Altorjay I, Löhr H, Koutroubakis I, Bar-Meir S, Stimac D, Schäffeler E, Glasmacher C, Dilger K, Mohrbacher R, Greinwald R; International Budenofalk Study Group. Tromm A, et al. Among authors: mohrbacher r. Gastroenterology. 2011 Feb;140(2):425-434.e1; quiz e13-4. doi: 10.1053/j.gastro.2010.11.004. Epub 2010 Nov 9. Gastroenterology. 2011. PMID: 21070781 Clinical Trial.
Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, Mohrbacher R, Levitt M, Greinwald R, Shapira MY. Elad S, et al. Among authors: mohrbacher r. Biol Blood Marrow Transplant. 2012 Jan;18(1):134-40. doi: 10.1016/j.bbmt.2011.06.001. Epub 2011 Jun 12. Biol Blood Marrow Transplant. 2012. PMID: 21703973 Free article. Clinical Trial.
Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK; BUC-60/COC Study Group. Miehlke S, et al. Among authors: mohrbacher r. Gastroenterology. 2014 May;146(5):1222-30.e1-2. doi: 10.1053/j.gastro.2014.01.019. Epub 2014 Jan 15. Gastroenterology. 2014. PMID: 24440672 Free article. Clinical Trial.
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.
Kreisel W, Deibert P, Kupcinskas L, Sumskiene J, Appenrodt B, Roth S, Neagu M, Rössle M, Zipprich A, Caca K, Ferlitsch A, Dilger K, Mohrbacher R, Greinwald R, Sauerbruch T. Kreisel W, et al. Among authors: mohrbacher r. Dig Liver Dis. 2015 Feb;47(2):144-50. doi: 10.1016/j.dld.2014.10.018. Epub 2014 Nov 15. Dig Liver Dis. 2015. PMID: 25483910 Clinical Trial.
Smoking Status Influences Clinical Outcome in Collagenous Colitis.
Münch A, Tysk C, Bohr J, Madisch A, Bonderup OK, Mohrbacher R, Mueller R, Greinwald R, Ström M, Miehlke S. Münch A, et al. Among authors: mohrbacher r. J Crohns Colitis. 2016 Apr;10(4):449-54. doi: 10.1093/ecco-jcc/jjv235. Epub 2015 Dec 30. J Crohns Colitis. 2016. PMID: 26721941 Free PMC article. Clinical Trial.
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
Kruis W, Kardalinos V, Eisenbach T, Lukas M, Vich T, Bunganic I, Pokrotnieks J, Derova J, Kondrackiene J, Safadi R, Tuculanu D, Tulassay Z, Banai J, Curtin A, Dorofeyev AE, Zakko SF, Ferreira N, Björck S, Diez Alonso MM, Mäkelä J, Talley NJ, Dilger K, Greinwald R, Mohrbacher R, Spiller R. Kruis W, et al. Among authors: mohrbacher r. Aliment Pharmacol Ther. 2017 Aug;46(3):282-291. doi: 10.1111/apt.14152. Epub 2017 May 23. Aliment Pharmacol Ther. 2017. PMID: 28543263 Free PMC article. Clinical Trial.
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
Kruis W, Neshta V, Pesegova M, Alekseeva O, Andreev P, Datsenko O, Levchenko O, Abdulkhakov S, Lozynskyy Y, Mostovoy Y, Soloviev K, Dorofeyev AE, Vieth M, Stiess M, Greinwald R, Mohrbacher R, Siegmund B. Kruis W, et al. Among authors: mohrbacher r. Clin Gastroenterol Hepatol. 2019 Jan;17(1):98-106.e4. doi: 10.1016/j.cgh.2018.04.027. Epub 2018 Apr 24. Clin Gastroenterol Hepatol. 2019. PMID: 29702300 Free article. Clinical Trial.
Distribution of histopathological features along the colon in microscopic colitis.
Fiehn AK, Miehlke S, Aust D, Vieth M, Bonderup O, Fernández-Bañares F, Mihaly E, Kupcinskas J, Madisch A, Munck LK, Nacak T, Mohrbacher R, Mueller R, Greinwald R, Münch A. Fiehn AK, et al. Among authors: mohrbacher r. Int J Colorectal Dis. 2021 Jan;36(1):151-159. doi: 10.1007/s00384-020-03747-z. Epub 2020 Sep 12. Int J Colorectal Dis. 2021. PMID: 32920702
28 results